Table 3.
Percentage of AD patients and Healthy controls with FLG LoFs in USA, Europe, and Asia.
Global studies on AD | Study population | Patients carrying at least one FLG LoF (%) | Controls carrying at least one FLG LoF (%) |
---|---|---|---|
Polcari et al. (2014) | United States (African American) | 22.2% (4/18) | 5.8% (1/17) |
Greisenegger et al. (2010) | Austria and Germany | 22.9% (106/462) | 7.7% (31/402) |
Sandilands et al. (2007) | Ireland | 45.2% (85/188) | 7.6% (56/736) |
Zhang et al. (2011) | Han Chinese | 31.4% (82/261) | 0 (0/92) |
Park et al. (2015) | Korean | 16.04% (13/81) | NA |
Nomura et al. (2007) | Japan | 20.5% (21/102) | 0 (0/156) |
Our study | India | 13% (3/23) | 3.2% (1/31) |